Travere Therapeutics, Inc.
TVTXCIK 0001438533 · Pharmaceutical Preparations · Nasdaq
- Retrophin, Inc. (until 2020-11-13)
- Desert Gateway, Inc. (until 2013-02-19)
Revenue (TTM)
$488.24M
+110.5% YoY
Q1 Apr 2026
Net Income (TTM)
−$65.38M
+92.1% YoY
Q1 Apr 2026
EPS Diluted (TTM)
−$0.73
+92.9% YoY
Q1 Apr 2026
Gross Margin
98.0%
Q1 Apr 2026
Operating Margin
-13.8%
Q1 Apr 2026
Net Margin
-13.4%
Q1 Apr 2026
Free Cash Flow (TTM)
−$287.94M
Q1 Apr 2026
Cash
$78.36M
Q1 Apr 2026
Total Debt
$46M
Q1 Apr 2026
Shares Outstanding
92.99M sh
Q1 Apr 2026